Finance

Lists
Why is ANIK down 2.97%?
Dive Deeper
ANIK:NASDAQ
Anika Therapeutics Inc
$13.40
-2.97%
(-0.41) 1D
Nov 13, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ANIK...
Open
$13.89
High
$13.97
Low
$13.26
Mkt. cap
179.50M
Avg. vol.
117.48K
Volume
87.85K
52-wk high
$22.88
52-wk low
$9.01
EPS
-$0.27
Beta
0.21
Shares outstanding
13.40M
No. of employees
235
Open
$13.89
High
$13.97
Low
$13.26
Mkt. cap
179.50M
Avg. vol.
117.48K
Volume
87.85K
52-wk high
$22.88
52-wk low
$9.01
EPS
-$0.27
Beta
0.21
Shares outstanding
13.40M
No. of employees
235
News stories
From web sources and news partners
About Anika Therapeutics Inc
CEO-
Employees235
Founded1983
HeadquartersBedford, Massachusetts, United States
SectorHealth Care
IndustryBiotechnology
Websiteanika.com
Analyst ratings
Based on 2 analysts giving stock ratings to ANIK in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for ANIK in the last 3 months.
Highest
Current $13.40
$23.00 (+71.64%)
Average
$23.00 (+71.64%)
Lowest
$23.00 (+71.64%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Petusky
Barrington
Buy
Maintained
$23.00
+71.6%
11/09/2026
Madison Elsaadi
B. Riley Securities
Buy
Initiated
$23.00
+71.6%
09/18/2026
Anderson Schock
B. Riley Securities
Buy
Maintained
$21.00
+56.7%
07/30/2026
Last report
Nov 6, 2026
Fiscal period
Q3 2026
$0.29 / $0.17
+70.59%beat
Revenue / Est. (USD)
30.59M / 29.44M
+3.94%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
30.62M
29.61M
32.61M
30.59M
Cost of goods sold
11.44M
10.62M
11.37M
11.76M
Cost of revenue
11.44M
10.62M
11.37M
11.76M
Research and development expenses
6.45M
6.71M
7.34M
7.90M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
12.08M
16.18M
10.18M
11.53M
Operating expense
18.53M
22.90M
17.52M
19.42M
Total operating expenses
29.97M
33.51M
28.88M
31.18M
Operating income
646.00K
-3.90M
3.73M
-585.00K
Other non operating income
-
-
-
-
EBT including unusual items
764.00K
-4.82M
3.38M
-322.00K
EBT excluding unusual items
764.00K
-3.23M
4.15M
-195.00K
Income tax expense
-1.04M
235.00K
71.00K
-11.00K
Effective tax rate
-135.73%
-4.87%
2.10%
3.42%
Other operating expenses
-
-
-
-
Net income
292.00K
-5.06M
3.31M
-311.00K
Net profit margin
0.95%
-17.07%
10.15%
-1.02%
Earnings per share
0.31
0.27
0.42
0.29
Interest and investment income
118.00K
667.00K
426.00K
390.00K
Interest expense
-
-
-
-
Net interest expenses
118.00K
667.00K
426.00K
390.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
1.96M
-2.49M
5.23M
854.00K
Gain or loss from assets sale
790.00K
-52.00K
-32.00K
90.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps